Sosei Group Corporation appointed Mr. Chris Cargill as Executive Vice President and Chief Financial Officer with immediate effect. Mr. Cargill was appointed Interim CFO in June 2018 having previously been a Senior Vice President in the Company. Prior to joining Sosei, Mr. Cargill spent nearly a decade in Investment Banking at J.P. Morgan and held various positions of increasing responsibility, most recently as Vice President in the U.K. Corporate Finance Group, focused on the Healthcare sector.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,507 JPY | -0.79% | -1.70% | +6.05% |
May. 31 | Nxera Pharma to Receive $4.6 Million Milestone Payments From Centessa Pharmaceuticals | MT |
May. 30 | Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.05% | 849M | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Sosei Group Corporation Appoints Chris Cargill as Executive Vice President and Chief Financial Officer